Related Experiment Video

Updated: Jun 2, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Induction of apoptosis in head and neck tumor-cell lines by anti-fas antibody

H Kumazawa1, T Tachikawa, S Sai

  • 1KANSAI MED UNIV,DEPT NEUROSURG,MORIGUCHI,OSAKA 570,JAPAN. KANSAI MED UNIV,DEPT PATHOL,MORIGUCHI,OSAKA 570,JAPAN.

International Journal of Oncology
|May 11, 2011
PubMed

Insights

This study explored programmed cell death (apoptosis) in head and neck tumors using anti-Fas antibody. Some tumor cells showed increased apoptosis, suggesting potential therapeutic strategies for head and neck cancers.

Area of Science:

  • Oncology
  • Cell Biology

Background:

  • Apoptosis is crucial for tissue homeostasis in renewing tissues.
  • Apoptosis in head and neck tumors is not well understood.

Purpose of the Study:

  • To investigate the induction of apoptosis in head and neck tumor cell lines using anti-Fas antibody.
  • To explore the potential of anti-Fas antibody as a therapeutic strategy for head and neck tumors.

Main Methods:

  • Culturing head and neck tumor cell lines (KB, KBrc, HSC-2,3,4) with anti-Fas antibody.
  • Light and electron microscopic examination of morphological changes.
  • Pretreatment with interferon-gamma to assess synergistic effects.

Main Results:

  • Anti-Fas antibody demonstrated varying antitumor effects across different cell lines.
  • Sensitive cell lines exhibited enhanced apoptosis upon anti-Fas antibody treatment.
  • Pretreatment with interferon-gamma further boosted apoptosis in sensitive cell lines.

Conclusions:

  • Inducing apoptosis via anti-Fas antibody shows promise for treating certain head and neck tumors.
  • Interferon-gamma may enhance the efficacy of anti-Fas antibody therapy.
  • Further research is warranted to explore this therapeutic approach.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells13:53

Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells

Published on: August 26, 2021

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.